Biolab's Pharmacovigilance department is responsible for identifying, evaluating, understanding and preventing adverse events and special situations that may occur during the use of our products.
DID YOU KNOW?
Although the term "pharmacovigilance" is more commonly known in relation to drug safety, there are other types of surveillance relating to the safety and efficacy of health products and cosmetics, such as technovigilance and cosmetovigilance.
WHAT ARE ADVERSE EVENTS AND SPECIAL SITUATIONS?
An adverse event is any undesirable medical occurrence in a patient who has used a medicine, without there necessarily being a causal relationship with the treatment. It can be any unfavorable and unintentional sign, symptom or disease temporally associated with the use of the medicine.
Special situations consist of any occurrence related to the use of medication, such as medication errors, use other than that described in the package leaflet, suspicions of use, etc. that the treatment is not being effective, drug abuse and overdose, accidental exposure, exposure during pregnancy or breastfeeding, in the workplace and drug interactions.
WHY REPORT AN ADVERSE EVENT?
Biolab's Pharmacovigilance department evaluates each adverse event reported. Based on this information, it is possible to continuously monitor the risk-benefit profile of our products, implement preventive measures, promote the rational use of medications and identify possible updates to the information on our products.
Therefore, it is important to report adverse events and special situations, even if you are not sure of the causal relationship with the product, even if the adverse event is already on the package leaflet.
All information received is kept confidential, in compliance with current legislation.
To find out more about protecting your data, click here.
HOW TO REPORT ADVERSE EVENTS OR SPECIAL SITUATIONS?
To report an adverse event related to one of our products, you can fill in the form or contact us by phone or e-mail.
